An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...

Most people recover from norovirus, a highly contagious infection, within a few days but it can be particularly risky for ...

As well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...

The first anti-amyloid monoclonal antibody -- and the first drug of any kind aimed at the Alzheimer's disease process -- gained FDA approval in June 2021: aducanumab (Aduhelm). However ...